GSE212377
Columbia University Irving Medical Center RNASeq of meningioma tumors
We use a Master Regular-based precision cancer medicine framework to predict drug sensitivity to tumors. Overall design: RNAseq profiles of 102 meningioma patient tumors sequenced at Columbia University Irving Medical Center used to derive a meningioma gene regulatory network (interactome).